Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Mabylon raised a total of €31.8 million in capital funding

Mabylon raised a total of €31.8 million in capital funding

Biotech Health services Pharma

Switzerland

Investments

13 July 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Mabylon (company)

Switzerland

Biotech Health services Pharma

Total investments received (USD): 37.21M

Round value (USD): 37.21M

Round investors:

Company: Mabylon

Industry: Biotech Health services Pharma

Related deals

EvlaBio secures €21 million Seed Funding led by Kurma Partners as well as AdBio Partners, Boehringer Ingelheim, NRW.Venture (NRW.BANK) and HTGF .

Biotech Health services Manufacturing Pharma

Switzerland

Germany

France

Investments 02 July 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top